Evidence map›Paper›PMID 26672497›Full record

ArticleWorld journal of gastrointestinal endoscopy2015

Race and colorectal cancer screening compliance among persons with a family history of cancer.

Adeyinka O Laiyemo, Nicole Thompson, Carla D Williams, Kolapo A Idowu, Kathy Bull-Henry, Zaki A Sherif, Edward L Lee, Hassan Brim, Hassan Ashktorab, Elizabeth A Platz and 1 more

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Adeyinka O LaiyemoAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Nicole ThompsonAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Carla D WilliamsAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Kolapo A IdowuAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Kathy Bull-HenryAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Zaki A SherifAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Edward L LeeAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Hassan BrimAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Hassan AshktorabAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Elizabeth A PlatzAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Duane T SmootAdeyinka O Laiyemo, Hassan Ashktorab, Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, United States.
Meharry Medical College · US

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Maternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8M
PROTEOMICS CORE FACILITYG12MD007597 · NIMHD · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 2012 to 2018
$14.8M
Institutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5M
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUKL2TR000102 · NCATS · GEORGETOWN UNIVERSITY · PI MELLMAN, THOMAS A, VERBALIS, JOSEPH G · 2012 to 2014
$1.7M
Improving attendance to outpatient endoscopy appointments among blacksR21DK100875 · NIDDK · HOWARD UNIVERSITY · PI LAIYEMO, ADEYINKA O · 2014 to 2015
$415k
NCATS NIH HHS KL2 TR000102NCATS NIH HHS KL2 TR001432NCATS NIH HHS UL1 TR001409NCI NIH HHS P30 CA006973NIDDK NIH HHS R21 DK100875NIMHD NIH HHS G12 MD007597
6 · The paper itself

Abstract

aimTo determine compliance to colorectal cancer (CRC) screening guidelines among persons with a family history of any type of cancer and investigate racial differences in screening compliance.

methodsWe used the 2007 Health Information National Trends Survey and identified 1094 (27.4%) respondents (weighted population size = 21959672) without a family history of cancer and 3138 (72.6%) respondents (weighted population size = 58201479) with a family history of cancer who were 50 years and older. We defined compliance with CRC screening as the use of fecal occult blood testing within 1 year, sigmoidoscopy within 5 years, or colonoscopy within 10 years. We compared compliance with CRC screening among those with and without a family member with a history of cancer.

resultsOverall, those with a family member with cancer were more likely to be compliant with CRC screening (64.9% vs 55.1%; OR = 1.45; 95%CI: 1.20-1.74). The absolute increase in screening rates associated with family history of cancer was 8.2% among whites. Hispanics had lowest screening rates among those without family history of cancer 41.9% but had highest absolute increase (14.7%) in CRC screening rate when they have a family member with cancer. Blacks had the lowest absolute increase in CRC screening (5.3%) when a family member has a known history of cancer. However, the noted increase in screening rates among blacks and Hispanics when they have a family member with cancer were not higher than whites without a family history of cancer: (54.5% vs 58.7%; OR = 1.16; 95%CI: 0.72-1.88) for blacks and (56.7% vs 58.7%; OR = 1.25; 95%CI: 0.72-2.18) for Hispanics.

conclusionWhile adults with a family history of any cancer were more likely to be compliant with CRC screening guidelines irrespective of race/ethnicity, blacks and Hispanics with a family history of cancer were less likely to be compliant than whites without a family history. Increased burden from CRC among blacks may be related to poor uptake of screening among high-risk groups.

Indexed as

Colon cancerColonoscopyFecal blood testHealth disparitiesScreening

Identifiers

PMID26672497
PMCPMC4673393
OpenAlexW2345548989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.